Ruxandra Draghia-Akli - 11 Nov 2024 Form 3 Insider Report for NOVAVAX INC (NVAX)

Role
Section 16
Signature
/s/Mark J. Casey, Attorney-in-Fact
Issuer symbol
NVAX
Transactions as of
11 Nov 2024
Net transactions value
$0
Form type
3
Filing time
13 Nov 2024, 16:05:53 UTC
Next filing
05 Mar 2025

No securities are beneficially owned.

Remarks:

No Securities are beneficially held.